Pilot study of WT1 peptide vaccine therapy for chemorefractory advanced pancreatic cancer.

Trial Profile

Pilot study of WT1 peptide vaccine therapy for chemorefractory advanced pancreatic cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Jan 2011

At a glance

  • Drugs INNO 305 (Primary)
  • Indications Pancreatic cancer
  • Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
  • Acronyms PDAC-WT1
  • Most Recent Events

    • 06 Jan 2011 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 22 Dec 2009 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
    • 22 Dec 2009 Actual initiation date (Jan 2009) added as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top